Guidelines for authors

Summary Brief

1. WHO IS OUR TARGET AUDIENCE

This educational activity is intended for comprehensive ophthalmologists, ophthalmology residents and fellows.

2. WHAT ARE OUR EDUCATIONAL OBJECTIVES

Medical knowledge, professionalism and patient care. Each issue has its own educational objectives that were established to guide the development of the content.

3. INSTRUCTIONAL FORMAT

Glaucoma Now is an eight to sixteen page newsletter-format, enduring material published three times a year. Each issue has a major theme. Within each issue there are four sections, each of which treats some aspect of the theme in a predefined way.

`Special Focus` is a major review that outlines the expert consensus on the topic area, bringing together research findings and the judgement of highly regarded clinical scientists (length of chapter: 4 pages, approximately 2000 words; number of illustrations: 4-6; number of references: 15-20). `What's new` examines research directions and the latest findings in the theme area (length of chapter: 2 pages, approximately 1000 words; number of illustrations: 3-4; number of references: 5-10).
`Clinical Issues` relates research to clinical practice (length of chapter: 1 page, approximately 550 words; number of illustrations: 1-2; number of references: 3-6).

`Practical Tips` describes a related technique or procedure in sufficient detail to allow its immediate adoption in the clinic (length of chapter: 1 page, approximately 550 words; number of illustrations: 1-2; number of references: 1-5).

4. NEEDS ASSESSMENT

Advances in the diagnosis and treatment of glaucoma are taking place with enormous speed. On May 4 of 2016, a PubMed search under the keyword glaucoma found 1236 peer-reviewed papers published on the subject in the current year alone.
From a clinical perspective, however, glaucoma is neither diagnosed nor treated exclusively by subspecialists. Rather, glaucoma is widely treated by comprehensive and general ophthalmologists, who are greatly challenged to keep up with that volume of research.
In each of the three projected annual issues of `Glaucoma now`, a major topic area in glaucoma damage mechanisms, pathogenesis, diagnosis, or management will be addressed by pre-eminent global authorities in the field. These individuals are asked to review and summarize advances with an emphasis on incorporating them into everyday practice.

Dear Author,
to help us put this current edition together within the timeframe specified in our invitation letter we would like to ask you for the following:

  • Please ensure that the article is clear, comprehensive, evidence-based, unbiased and that it is adequately referenced (peer reviewed publications).
  • Please be aware of the other three articles in the issue (listed above) in which your contribution will appear in order to avoid repetition.
  • Please aim for maximal visual impact with adequate illustrations, graphs, etc. to emphasize the content.
  • If needed - a standard form to to obtain permission for published material is available on this webpage

We would like to thank you for your support!

 

Download literature request form here.
Download author disclosure form here.

Please make sure to also fill in the author disclosure form and send back to the contact address listed within.

Quick Search

EDITORS

Ivan Goldberg

MD, FRANZCO, FRACS
Sydney Eye Hospital,
Sydney, NSW, Australia



Remo Susanna Jr MD,

Department of Ophthalmology, University of São Paulo,
São Paulo, Brazil